RT Journal Article
SR Electronic
T1 A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007135
DO 10.1136/jitc-2023-007135
VO 12
IS 1
A1 Desroys du Roure, Pénélope
A1 Lajoie, Laurie
A1 Mallavialle, Aude
A1 Alcaraz, Lindsay B
A1 Mansouri, Hanane
A1 Fenou, Lise
A1 Garambois, Véronique
A1 Rubio, Lucie
A1 David, Timothée
A1 Coenon, Loïs
A1 Boissière-Michot, Florence
A1 Chateau, Marie-Christine
A1 Ngo, Giang
A1 Jarlier, Marta
A1 Villalba, Martin
A1 Martineau, Pierre
A1 Laurent-Matha, Valérie
A1 Roger, Pascal
A1 Guiu, Séverine
A1 Chardès, Thierry
A1 Gros, Laurent
A1 Liaudet-Coopman, Emmanuelle
YR 2024
UL http://jitc.bmj.com/content/12/1/e007135.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.